235 related articles for article (PubMed ID: 16107075)
1. Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis.
Kelly DF; Rappuoli R
Adv Exp Med Biol; 2005; 568():217-23. PubMed ID: 16107075
[TBL] [Abstract][Full Text] [Related]
2. The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.
Masignani V; Pizza M; Moxon ER
Front Immunol; 2019; 10():751. PubMed ID: 31040844
[TBL] [Abstract][Full Text] [Related]
3. Approach to the Discovery, Development, and Evaluation of a Novel Neisseria meningitidis Serogroup B Vaccine.
Green LR; Eiden J; Hao L; Jones T; Perez J; McNeil LK; Jansen KU; Anderson AS
Methods Mol Biol; 2016; 1403():445-69. PubMed ID: 27076147
[TBL] [Abstract][Full Text] [Related]
4. Antigen identification starting from the genome: a "Reverse Vaccinology" approach applied to MenB.
Palumbo E; Fiaschi L; Brunelli B; Marchi S; Savino S; Pizza M
Methods Mol Biol; 2012; 799():361-403. PubMed ID: 21993656
[TBL] [Abstract][Full Text] [Related]
5. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
Bai X; Borrow R
Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270
[TBL] [Abstract][Full Text] [Related]
6. Genome-based vaccine development: a short cut for the future.
Moriel DG; Scarselli M; Serino L; Mora M; Rappuoli R; Masignani V
Hum Vaccin; 2008; 4(3):184-8. PubMed ID: 20686357
[TBL] [Abstract][Full Text] [Related]
7. Neisseria meningitidis B vaccines.
Panatto D; Amicizia D; Lai PL; Gasparini R
Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
[TBL] [Abstract][Full Text] [Related]
8. Reverse vaccinology--in search of a genome-derived meningococcal vaccine.
Danzig L
Vaccine; 2006 Apr; 24 Suppl 2():S2-11-2. PubMed ID: 16823908
[TBL] [Abstract][Full Text] [Related]
9. A universal vaccine for serogroup B meningococcus.
Giuliani MM; Adu-Bobie J; Comanducci M; Aricò B; Savino S; Santini L; Brunelli B; Bambini S; Biolchi A; Capecchi B; Cartocci E; Ciucchi L; Di Marcello F; Ferlicca F; Galli B; Luzzi E; Masignani V; Serruto D; Veggi D; Contorni M; Morandi M; Bartalesi A; Cinotti V; Mannucci D; Titta F; Ovidi E; Welsch JA; Granoff D; Rappuoli R; Pizza M
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10834-9. PubMed ID: 16825336
[TBL] [Abstract][Full Text] [Related]
10. Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention.
Esposito S; Castellazzi L; Bosco A; Musio A; Stoddard J
Immunotherapy; 2014; 6(4):395-408. PubMed ID: 24815780
[TBL] [Abstract][Full Text] [Related]
11. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.
Mameli C; Galli E; Mantegazza C; Fabiano V; Zuccotti GV
Future Microbiol; 2015; 10(10):1579-98. PubMed ID: 26437903
[TBL] [Abstract][Full Text] [Related]
12. Neisseria meningitidis serogroup B vaccine development.
Caesar NM; Myers KA; Fan X
Microb Pathog; 2013 Apr; 57():33-40. PubMed ID: 23416222
[TBL] [Abstract][Full Text] [Related]
13. Genome-based approaches to develop vaccines against bacterial pathogens.
Serruto D; Serino L; Masignani V; Pizza M
Vaccine; 2009 May; 27(25-26):3245-50. PubMed ID: 19200820
[TBL] [Abstract][Full Text] [Related]
14. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.
Bambini S; Muzzi A; Olcen P; Rappuoli R; Pizza M; Comanducci M
Vaccine; 2009 May; 27(21):2794-803. PubMed ID: 19428890
[TBL] [Abstract][Full Text] [Related]
15. The promise of reverse vaccinology.
Heinson AI; Woelk CH; Newell ML
Int Health; 2015 Mar; 7(2):85-9. PubMed ID: 25733557
[TBL] [Abstract][Full Text] [Related]
16. Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis.
Tsolakos N; Brookes C; Taylor S; Gorringe A; Tang CM; Feavers IM; Wheeler JX
J Proteomics; 2014 Apr; 101():63-76. PubMed ID: 24561796
[TBL] [Abstract][Full Text] [Related]
17. The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.
Zlotnick GW; Jones TR; Liberator P; Hao L; Harris S; McNeil LK; Zhu D; Perez J; Eiden J; Jansen KU; Anderson AS
Hum Vaccin Immunother; 2015; 11(1):5-13. PubMed ID: 25483509
[TBL] [Abstract][Full Text] [Related]
18. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.
Murphy E; Andrew L; Lee KL; Dilts DA; Nunez L; Fink PS; Ambrose K; Borrow R; Findlow J; Taha MK; Deghmane AE; Kriz P; Musilek M; Kalmusova J; Caugant DA; Alvestad T; Mayer LW; Sacchi CT; Wang X; Martin D; von Gottberg A; du Plessis M; Klugman KP; Anderson AS; Jansen KU; Zlotnick GW; Hoiseth SK
J Infect Dis; 2009 Aug; 200(3):379-89. PubMed ID: 19534597
[TBL] [Abstract][Full Text] [Related]
19. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
20. Reverse vaccinology: a genome-based approach for vaccine development.
Masignani V; Rappuoli R; Pizza M
Expert Opin Biol Ther; 2002 Dec; 2(8):895-905. PubMed ID: 12517268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
